The 17 references in paper A. Mudunov M., M. Narimanov N., D. Safarov A., B. Dolgushin I., A. Akhundov A., I. Trofimov A., А. Мудунов М., М. Нариманов Н., Д. Сафаров А., Б. Долгушин И., А. Ахундов А., И. Трофимов А. (2018) “Обзор возможностей регионарной интраартериальной химиотерапии в лечении плоскоклеточного рака полости носа и придаточных пазух // Review of the possibilities of regional intra-arterial chemotherapy in the treatment of squamous cell carcinoma of the nasal cavity and paranasal sinuses” / spz:neicon:ogsh:y:2018:i:1:p:56-61

1
Ock C.Y., Keam B., Kim T.M. et al. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation. Korean J Intern Med
(check this in PDF content)
2
16;31(3):570–8. DOI: 10.3904/ kjim.2015.020. 2. Reyes-Gibby C.C., Anderson K.O., Merriman K.W. et al. Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival. J Pain 2014;15(10):1015–22. DOI: 10.1016/j.jpain.2014.07.003.
(check this in PDF content)
3
Fernström E., Nyman J., Hammerlid E. et al. Results of preoperative chemoradiotherapy for patients with advanced cancer of the nasal cavity and paranasal sinuses. Acta Otolaryngol 2017;137(12):1292–300. DOI: 10.1080/00016489.2017.1357081.
(check this in PDF content)
4
Bristol I.J., Ahamad A., Garden A.S. et al. Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment. Int J Radiat Oncol Biol Phys 2007;68(3):719–30. DOI: 10.1016/j.ijrobp.2007.01.032.
(check this in PDF content)
5
Dimery I.W., Hong W.K. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993;85(2):95–111. DOI: 10.1093/ jnci/85.2.95.
(check this in PDF content)
6
International Nasopharynx Cancer Study Group. Preliminary results of randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (>N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 1996;35(3):463–9. PMID: 8655368.
(check this in PDF content)
7
Sanders I.W., Haslet K., Correa P. et al. Sequential TPF chemotherapy followed by concurrent chemoradiotherapy in locally advanced head and neck cancer – a retrospective analysis of toxicity and outcomes. Scottish Med J 2014;59(1): 50–5. DOI: 10.1177/0036933013518153.
(check this in PDF content)
8
Lorch J.H., Goloubeva O., Haddad R.I. et al. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol 2011;12(2):153–9. DOI: 10.1016/S1470-2045(10)70279-5.
(check this in PDF content)
9
Kim J.H., Lee Y.S., Chung Y.-S. et al. Treatment outcomes of concurrent chemoradiotherapy for locally advanced sinonasal squamous cell carcinoma: A single-institution study. Acta Otolaryngol 2015;135(11):1189–95. DOI: 10.3109/00016489.2015.1061697.
(check this in PDF content)
10
Garavello W., Ciardo A., Spreafico R., Gaini R.M. Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006;132(7):762–6. DOI: 10.1001/ archotol.132.7.762.
(check this in PDF content)
11
Richard J.M., Sancho H., Lepintre Y. et al. Intra-arterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx. Cancer 1974;34:491–6.
(check this in PDF content)
12
Robbins K.T., Kumar P., Wong F.C. et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 2000;22(7):687–93. PMID: 11002324.
(check this in PDF content)
13
Foote R.L., Kasperbauer J.L., Okuno S.H. et al. A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive tract. Cancer 2005;103(3):559–68. DOI: 10.1002/cncr.20803.
(check this in PDF content)
14
Rabbani A., Hinerman R.W., Schmal- fuss I.M. et al. Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous cell carcinomas of the head and neck. Am J Clin Oncol 2007;30(3):283–6. DOI: 10.1097/01.coc.0000258118.38177.74.
(check this in PDF content)
15
Homma А., Sakashita T., Yoshida D. et. al. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer. Br J Cancer 2013;109:2980–6. DOI: 10.1038/ bjc.2013.663.
(check this in PDF content)
16
Furusaka T., Asakawa T., Tanaka A., Ikeda M. Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer. Acta Otolaryngol 2012;132(10):1108–14. DOI: 10.3109/00016489.2012.684702.
(check this in PDF content)
17
Namon A.J., Panje W.R. Controversy in the management of tumors of the nasal cavity and paranasal sinuses. In: Comprehensive Management of Head and Neck Tumors. 2nd ed. Eds.: S.E. Thawley,
(check this in PDF content)